Top News

Sanofi Completes $4.8-Billion Ablynx Acquisition

June 20, 2018

The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.

Roche to Acquire Foundation Medicine for $2.4 Billion

June 20, 2018

The acquisition is expected to strengthen Roche’s personalized healthcare strategy.

Bayer Completes Monsanto Acquisition for $63 Billion

June 13, 2018

Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.

Bayer Gets US Approval for $66-Billion Acquisition of Monsanto

May 30, 2018

Bayer received conditional approval from the Antitrust Division of the United States Department of Justice to acquire Monsanto in a deal worth $66 billion.

Novartis Acquires AveXis for $8.7 Billion

May 16, 2018

The acquisition is expected to strengthen Novartis’ gene therapy pipeline.

Lilly to Acquire ARMO BioSciences for $1.6 Billion

May 15, 2018

Eli Lilly will acquire ARMO BioSciences to strengthen Lilly's immuno-oncology program.

J&J’s Janssen to Acquire BeneVir for $1 Billion

May 09, 2018

Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.

Takeda to Acquire Shire for $62 Billion

May 09, 2018

Takeda expands its global and therapy base with announced acquisition of Shire.

Fresenius Terminates $4.3-Billion Merger with Akron

May 01, 2018

Fresenius Kabi claims that Akorn failed to fulfill several closing conditions.

Merck KGaA to Sell Consumer Health Biz to Procter & Gamble for $4.2 Billion

April 19, 2018

The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.